Search Within

Wassim Abida

Formats
  1. Meeting Abstract (75)
  2. Journal Article (72)
  3. Editorial (4)
  4. Review (3)
  5. Research Letter (2)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (158)
  2. Genitourinary Oncology Service (158)
  3. Solid Tumor Oncology Division (158)
  4. GSK Faculty (72)
  5. Human Oncology and Pathogenesis Program (68)
  6. Sloan Kettering Institute Postdocs (60)

More Groups

People
  1. Howard Scher (68)
  2. Michael Morris (39)
  3. David Solit (36)
  4. Nikolaus Schultz (33)
  5. Anuradha Gopalan (31)
  6. Dana Rathkopf (31)

More People

Years
  1. 2025 (8)
  2. 2024 (10)
  3. 2023 (14)
  4. 2022 (15)
  5. 2021 (19)
  6. 2020 (27)

More Years

Publications
  1. Journal of Clinical Oncology (40)
  2. Clinical Cancer Research (15)
  3. Annals of Oncology (13)
  4. Cancer Research (13)
  5. European Urology (8)
  6. JCO Precision Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (44)
  2. American Association for Cancer Research (31)
  3. Nature Publishing Group (15)
  4. Oxford University Press (13)
  5. Elsevier Science, Inc. (10)
  6. Nature Research (5)

More Publishers

Results (158)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib open-label, dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with abiraterone or enzalutamide in metastatic castrate-resistant prostate cancer
    Meeting Abstract

    Vaishampayan, U. N.; Narayan, V.; Wise, D.; Lang, J. M.; Lowentritt, B. H.; Mellado, B.; Carles, J.; Saez, M. I.; Abida, W.; Taplin, M. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • TRITON3: An international, randomized, open-label, phase III study of the PARP inhibitor rucaparib vs. physician's choice of therapy for patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
    Meeting Abstract

    Ryan, C. J.; Abida, W.; Bryce, A. H.; Balar, A. V.; Dumbadze, I.; Given, R. W.; Morris, D.; Petrylak, D. P.; Redfern, C. H.; Scher, H. I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naive prostate cancer that retains RB expression
    Meeting Abstract

    Kelly, W. K.; Godwin, J. L.; Hoffman-Censits, J. H.; Knudsen, K. E.; De Leeuw, R.; Leiby, B. E.; Southwell, T.; Hubert, C.; Smith, D. C.; Chatta, G. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • TRITON2: An international, multicenter, open-label, phase II study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
    Meeting Abstract

    Abida, W.; Bryce, A. H.; Balar, A. V.; Chatta, G. S.; Dawson, N. A.; Guancial, E. A.; Hussain, A.; Jha, G. G.; Lipsitz, D. U.; Patnaik, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
    Journal Article

    Rodrigues, D. N.; Rescigno, P.; Liu, D.; Yuan, W.; Carreira, S.; Lambros, M. B.; Seed, G.; Mateo, J.; Riisnaes, R.; Mullane, S.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
    Journal Article

    Hieronymus, H.; Murali, R.; Tin, A.; Yadav, K.; Abida, W.; Moller, H.; Berney, D.; Scher, H.; Carver, B.; Scardino, P.; more...
    eLife (2018)

    Fulltext@MSK | Save
  • Lineage plasticity in antiandrogen resistance
    Meeting Abstract

    Abida, W.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • The long tail of oncogenic drivers in prostate cancer
    Journal Article

    Armenia, J.; Wankowicz, S. A. M.; Liu, D.; Gao, J.; Kundra, R.; Reznik, E.; Chatila, W. K.; Chakravarty, D.; Han, G. C.; Coleman, I.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • Pathologic characterization of speckle-type POZ protein (SPOP)-mutated prostate cancer
    Meeting Abstract

    Peng, Y. C.; Abida, W.; DeLair, D.; Sirintrapun, S. J.; Chen, Y. B.; Al-Ahmadie, H.; Fine, S. W.; Tickoo, S.; Scher, H.; Reuter, V.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Targeting DNA repair in prostate cancer
    Journal Article

    Abida, W.; Sawyers, C. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save